Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
Ipamorelin
GH Increase2-3x
Studies8
Participants1,286
StatusAvailable

Ipamorelin

Selective Growth Hormone Secretagogue (GHRP)

Ipamorelin is a selective growth hormone releasing peptide (GHRP) that specifically stimulates the release of growth hormone without affecting other hormones. Unlike other GHRPs, Ipamorelin does not increase cortisol, acetylcholine, prolactin, or aldosterone levels, making it the most selective and well-tolerated growth hormone secretagogue available for research and therapeutic applications.

Complete Dosing Guide

Quick Reference

100-300
Typical Dose
Daily
Frequency
Approximately
Half-Life
SubQ
Route

Administration Method

Subcutaneous injection 1-3 times daily

Step-by-Step Dosing Protocol

Initial
100-300 mcg daily (split doses)
Getting started
Follow gradual escalation approach
Maintenance
Optimized dose
Sustained benefits
Continue at effective dose
Cycling
Break period
Recovery
Take breaks to maintain effectiveness

Dosing Guidelines

Research Protocol

Initial dosing begins at 100 mcg once daily, typically administered in the evening to complement natural growth hormone pulsatile release. After 1-2 weeks of tolerance assessment, dosing can be increased to 100 mcg twice daily (morning and evening), and subsequently to 100 mcg three times daily (morning, post-workout, and bedtime) for a total daily dose of 300 mcg. Doses are administered via subcutaneous injection on an empty stomach for optimal absorption and GH release.

Simple Explanation

Most people start with a small dose (100 mcg) once a day in the evening to test how their body responds. After a week or two, you can increase to twice a day (morning and evening). Eventually, some people take it three times a day - when they wake up, after workouts, and before bed. The key is to take it on an empty stomach (at least 1 hour before or 2 hours after eating) for the best results.

Mixing & Injection

Technical Instructions

Subcutaneous injection using insulin syringes (typically 0.5mL/1mL capacity with 29-31 gauge needles). Common injection sites include the abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water (typical ratio: 2mL bacteriostatic water per 5mg vial). Store reconstituted solution refrigerated and use within 28 days.

Step-by-Step Guide

Subcutaneous injection using insulin syringes (typically 0.5mL/1mL capacity with 29-31 gauge needles). Common injection sites include the abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water (typical ratio: 2mL bacteriostatic water per 5mg vial). Store reconstituted solution refrigerated and use within 28 days.

Clinical Administration Guidelines

Injection Protocol

  • Subcutaneous injection per protocol
  • Rotate injection sites
  • Consistent daily timing
  • Follow protocol guidelines

Monitoring Schedule

  • Regular progress monitoring
  • Health parameter monitoring
  • Laboratory monitoring
  • Safety monitoring

Dosage Calculator

Loading Calculator...

Medical Disclaimer

Ipamorelin is currently in research phase and is not FDA-approved for human therapeutic use. This information is for educational purposes only and should not replace consultation with healthcare providers. Individual results may vary. Medical supervision is recommended for all research applications.